The global anatomic pathology market is segmented on the basis of product & service and application. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.
According to a new market research report " Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021 " , published by MarketsandMarkets™.
The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021.
Don’t miss the opportunities in global anatomic pathology market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
Key players operating in the anatomic pathology market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).
Browse and in-depth TOC on "anatomic pathology market"
80 – Tables
32 – Figures
129 – Pages
On the basis of product and service, the anatomic pathology market is segmented into instruments, consumables, and services. The instruments segment has been subsegmented into tissue processing systems, slides staining systems, microtomes, and other instruments. Similarly, the consumables segment has been subsegmented into reagents & antibodies, probes, kits, and other consumables.
On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and other applications. The disease diagnosis segment accounted for the largest market share in 2016. The rapid growth in the aging population and increasing incidence of cancer and other chronic diseases is a key market driver in this segment.
Get your Queries Resolved | Speak to Our Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=137323145